Elevai Labs, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Elevai Labs, Inc. Common Stock generated cash of -$4,556,811, which is less than the previous year. Cash used in financing activities reached the amount of $6,738,890 last year. Net change in cash is therefore $2,171,950.
Cash Flow
| 2021 | -660.93K | -32.48K | 1.09M |
|---|---|---|---|
| 2022 | -1.58M | -32.02K | 2.36M |
| 2023 | -4.55M | -11.19K | 6.73M |
ELAB Cash Flow Statement (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Cash at beginning of period | 1.15M | 411.85K | 13.35K |
Operating activities | |||
Net income | -4.30M | -1.80M | -784.73K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 11.64K | 6.51K | 2.75K |
Stock-based compensation expense | 487.73K | 171.86K | 142.35K |
| Deferred income tax benefit | 487.73K | 171.86K | 142.35K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -23.21K | -11.54K | -1.35K |
Inventories | -265.52K | -69.32K | -160.81K |
Accounts payable | 466.89K | 65.19K | 192.08K |
Cash generated by operating activities | -4.55M | -1.58M | -660.93K |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -11.19K | -35.52K | -32.48K |
Acquisitions Net | 0 | 3.5K | 0 |
Cash generated by investing activities | -11.19K | -32.02K | -32.48K |
Financing activities | |||
Common Stock Issued | 7.46M | 2.17M | 1.09M |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 183.97K | 0 |
Cash used in financing activities | 6.73M | 2.36M | 1.09M |
Net Change In Cash | 2.17M | 743.04K | 398.50K |
Cash at end of period | 3.32M | 1.15M | 411.85K |